Format

Send to

Choose Destination
J Gastroenterol. 2014 Feb;49(2):185-94. doi: 10.1007/s00535-013-0931-x. Epub 2014 Jan 21.

TAK1 regulates hepatic cell survival and carcinogenesis.

Author information

1
Department of Medicine, University of California, San Diego, School of Medicine, La Jolla, CA, 92093, USA.

Abstract

TGF-β-activated kinase 1 (TAK1 or MAP3K7) is an intracellular hub molecule that regulates both nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways that play key roles in development, cell survival, immune response, metabolism, and carcinogenesis. TAK1 activity is tightly regulated by its binding proteins, TAB1 and TAB2/TAB3, as well as by post-translational modification including ubiquitination and phosphorylation. Accumulating evidence demonstrates that TAK1 plays a role in tumor initiation, progression, and metastasis as a tumor prompter or tumor suppressor. An understanding of the role of TAK1 in liver physiology and diseases is required for the development of therapeutic agencies targeting TAK1. In this review, we highlight the activation mechanism and pathophysiological roles of TAK1 in the liver.

PMID:
24443058
PMCID:
PMC3952073
DOI:
10.1007/s00535-013-0931-x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center